Open access peer-reviewed chapter

Polarization of Tumor-Associated Macrophages by Chinese Medicine Intervention: Mechanisms and Applications

Written By

Yuanjun Lu, Hor Yue Tan, Ning Wang and Yibin Feng

Submitted: 21 February 2019 Reviewed: 24 April 2019 Published: 29 May 2019

DOI: 10.5772/intechopen.86484

From the Edited Volume

Macrophage Activation - Biology and Disease

Edited by Khalid Hussain Bhat

Chapter metrics overview

1,193 Chapter Downloads

View Full Metrics


Macrophage polarization is a spectrum of phenotypes and generally can be classified into two states: (1) classically activated or M1 macrophages, which can be driven by lipopolysaccharide (LPS) alone or in association with Th1 cytokines and produce pro-inflammatory cytokines such as TNF-α, IL-6 and, IL-12, and (2) alternatively activated M2 macrophages, which can be promoted by Th2 mediators IL-4 and IL-13 and produce anti-inflammatory cytokines such as TGF-β and IL-10. Current studies have found that the phenotypic switch between M1 and M2 macrophages governs the fate of an organ in inflammation or injury. The imbalance of M1/M2 polarization is closely involved in various pathological processes and is becoming a potential target for therapeutic strategies. Traditional Chinese medicine is an integrated healthcare system composed of many practices and is characterized by multi-target, multi-level, and coordinated intervention effects. Chinese medicines nowadays are applied to regulate phenotype polarization of macrophages to improve the microenvironment, thus ameliorating or even eliminating the symptoms. In this chapter, we will discuss the molecular mechanisms of macrophage polarization, their roles in health and disease, and the intervention with Chinese medicines to modulate the polarization of macrophages in tumor microenvironment (TME) for therapeutic purpose.


  • tumor microenvironment
  • tumor-associated macrophage
  • polarization
  • Chinese medicine

1. Introduction

Primary and metastatic tumors are generally known as a complex ecosystem containing tumor cells and the surrounding environment, called tumor microenvironment (TME). Apart from autonomous changes by genetic alteration of tumor cells, the dynamic changes of TME progress the tumor progression [1]. TME is a multifaceted pool that consists of various cell types including neoplastic cells, stromal cells, and immune cells that interact with one another via numerous secreted cytokines, growth factors, and chemokines. Tumor-associated macrophages (TAMs) take up a large portion of recruited immune cells and constitute up to 50% of the tumor mass. It was reported that the high level of TAMs is associated with poor prognosis and decreasing overall survival in many cancers, such as liver, breast, gastric, and thyroid cancers, suggesting that TAMs certainly play essential roles during tumor development [2, 3, 4, 5, 6].

TAM recruitment and accumulation are regulated by various cytokines and chemokines, such as CCL2, CCL5, CCL7, CXCL12, etc., and growth factors including VEGF, PDGF, and CSF1, as well as other factors such as fibronectin and fibrinogen [7, 8, 9, 10]. CSF1 is the major regulator for monocyte proliferation and differentiation. CCL2 is a dominant attractant in many tumors. Since monocytes highly expressed the receptor of CCL2 (CCR2), most of tumors produced a high level of CCL2 that can intensely attract monocytes migrating toward CCL2-CCR2 axis [11, 12, 13, 14, 15, 16, 17]. However, CCL2 inhibition studies show that it could not completely suppress TAM accumulation, indicating that other factors affect this process [7, 17, 18, 19, 20, 21]. The CCL12-CXCR4 axis is reported to promote TAM regional accumulation under therapeutic treatments. In mice model, breast cancer highly expressed CCL20 and CCL5; Either inhibited CCL20 expression or treated with CCR5 antagonist, the number of TAMs was significantly reduced within tumors. These studies have shown that in breast cancer, CCL20-CCR6 and CCL5-CCR5 axes contribute to TAM accumulation. Another chemokine CCL11 can be induced under hypoxia condition and subsequently recruit TAMs to the hypoxic region.

In turn, TAMs can produce different molecules to remodel TME and influence fundamental aspects of tumor pathology. For instance, TAMs secrete endothelial growth factor (EGF) to increase neoplastic proliferation directly [22]; TAMs release vascular endothelial growth factors (VEGF) [23], angiogenic factor thymidine phosphorylase, and other chemokines including CCL2 and CXCL8 to enhance angiogenesis; TAMs produce metalloproteases (MMPs) to change TME matrix architecture for tumor metastasis [24]; and TAMs express immune regulatory molecules such as arginase-1 (ARG1), IL-10, and IL12 to modulate immune response [2]. The role of TAMs is accomplished by their phenotypic plasticity, either pro-inflammatory or anti-inflammatory phenotype, in response to the complex stimuli in TME. The double-edged sword feature of TAM polarization makes them as a novel and potent target for cancer prevention and treatments.

Traditional Chinese medicine is an integrated healthcare system composed of many practices that were rooted in China for over 5000 years. Due to its multi-target, multi-level, and coordinated intervention effects, Chinese medicine is widely used for therapeutic strategies. Recent studies reported that some of the Chinese herbal medicines have beneficial effects on cancer therapy via modulating TAM polarization, indicating a new mechanism for Chinese medicine treatment. In this chapter, we will explore the molecular mechanisms of TAM polarization and their roles in health and disease, and we will review the intervention by some of the Chinese herbal medicines on TAM polarization.


2. TAM polarization and molecular mechanisms

2.1 TAM polarization

It is widely accepted that the majority of TAMs are derived from circulating monocytes via cytokine recruitment and then differentiate to macrophages. And those at the metastatic sites are called metastatic-associated macrophages (MAMs) according to their location [25]. While recent studies have shown that the tissue-resident macrophages also contribute to TAM population [26, 27], these progenitors, also called embryonic macrophages, are derived from the yolk sac or fetal liver-derived progenitors, and they can maintain themselves by local proliferation in a hematopoietic system-independent way [28]. The selective depletion studies found that only the tissue-resident macrophages support the established tumor growth. Therefore, TAMs are heterogeneous cell populations from both tissue-resident macrophages and monocyte-derived macrophages and assist TME remodeling.

Besides their heterogeneity, TAMs are also characterized by high plasticity. In the general regard, macrophages can be overgeneralized to two extreme subsets based on the stimuli, surface markers, and secreted molecules, as well as functional properties: the classically activated M1 and alternatively activated M2 macrophages. The M1 phenotype is induced by the Th1 cytokine interferon-γ (IFN-γ), bacterial moieties such as lipopolysaccharide (LPS), and Toll-like receptor (TLR) agonists. The M1 macrophages are characterized by their capacity to produce inflammatory cytokines (e.g., IL-6, IL-1, IL-12, IL-23, and TNF-α) and stimulate immune response, express reactive oxygen species (ROS) and inducible nitric oxide synthase (iNOS), and have a cytotoxic effect toward neoplastic cells and phagocytic microorganisms [29, 30, 31, 32, 33, 34]. Generally, the M1-like macrophages act as sentries and display tumoricidal function, antimicrobial activity, and tissue destruction effect [33, 35].

In contrast, the M2 phenotype is promoted by Th2 mediators and produces immunosuppressive factors (e.g., IL-10, TGF-β) and growth factors (e.g., VEGF) and exerts anti-inflammatory and pro-tumorigenic activities [34, 36, 37]. Moreover, the M2-like macrophages can be further subdivided into three categories, M2a, M2b, and M2c, based on the type of stimuli. The M2a macrophages are driven by type II cytokines including IL4 and IL13 and expressed a high level of arginase-1; M2b macrophages are activated by immune complexes/TLR, while M2c macrophages by anti-inflammatory cytokines (e.g., IL-10) and glucocorticoids [38]. The M2-like macrophages promote angiogenesis, wound repair, and tumor growth, as well as resistance to parasitic infection. Many studies reported that TAMs mostly represent M2-like macrophages and play pro-tumoral roles.

2.2 Molecular mechanisms in regulating TAM polarization

2.2.1 The JNK signaling pathway

The c-Jun N-terminal kinase (JNK) proteins are a group of stress-activated serine threonine protein kinases of the MAPK and can be activated by various external stimuli including inflammatory cytokines, environmental stresses, growth factors, and GPCR agonists. The outside signals can be transduced by small GTPase to MAP3Ks and further activate MKK4/7. The MAP3Ks play key roles in the JNK pathway and affect tremendous downstream transcription factors including AP-1, Smad3, and STAT3, thus controlling many biological processes [39]. The studies on adipose tissue macrophages (ATMs) have demonstrated that the JNK pathway is indispensable in regulating M1/M2 phenotype formation. In HFD-/NAFLD-induced inflammation and obesity, the activated JNK pathway can promote the expression of the M1-associated genes via CCR2 and NF-κB signaling. The M1-like ATMs are related to the resistance to insulin [40, 41]. Recent studies found that normal adipocytes produce Th2 cytokines, such as IL-13 and IL-4 which can enhance M2-like macrophage polarization via activating STAT6 and PPAR𝛿/𝛽, as well as ACE to block the JNK pathway-induced M1-like phenotype [42]. Studies also found that vigorous exercise can promote M2 state through decrease phosphor-JNK [43].

2.2.2 The PI3K/Akt signaling pathway

Among different pathways, the PI3K/Akt pathway is playing a central role in regulating polarized phenotype alteration. It can be activated by many stimuli such as TLR4, PRRs, FcRs, and cytokines and modify downstream cytokine production [44, 45, 46, 47]. In turn, the PI3K/Akt pathway can affect the expression of stimuli and form a feedback loop. For example, the activated PI3K/Akt pathway can inhibit the transcription factors of TLR4 including TRAF6 and FOXO1 either directly or indirectly to suppress TLR4 stimulation. The PI3K has two transducers PIP2 and PIP3 which exert opposite functions during stimulation. It has been reported that PIP2 can enlarge LPS-induced M1-like macrophage polarization, while PIP3 can target mTORC2 via Akt recruitment and promote M2-like macrophage polarization. Other studies found that PTEN and SHIP play an inhibitory effect on PI3K/Akt transduction by transforming PIP3 to PIP2. The downstream signals mTORC1 and mTORC2 also participate in regulating M1/M2 alteration. Deletion of TSC1 can promote LPS-induced M1 polarization and inhibit IL-4-triggered M2 polarization via inhibiting mTORC1-induced Akt signaling, while the deletion of TSC2 gives an opposite response. Furthermore, the isoforms of Akt also contribute to influence the M1-/M2-polarized phenotype transformation in the opposite way. In knocked out Akt1, the expressions of iNOS and IL-12 were enhanced which is a hallmark of M1-like macrophages, and the transcription factor C/EBPβ of M2-related genes was decreased. The deletion of Akt2 led to C/EBPβ and M2 markers enhanced, including Arg1, Fizz1, and Ym1 [48].

2.2.3 The JAK/STAT signaling pathway

The JAK/STAT pathway is one of the principle regulators for transducing different signals and affects various gene expressions. The JAK family consists of JAK1–3 and TYK2 and can be recruited and bind to the intracellular domains of activated receptors. JAKs will subsequently become dimers after autophosphorylation and then phosphorylate their downstream STAT family which has seven members including STAT1–4, STAT5A/B, and STAT6. The activated STAT family will translocate to the nucleus and modulate the expression of their target genes [49]. Increasing evidence found that the JAK/STAT pathway is closely related to M1/M2 phenotypic polarization. Among different stimuli of JAK/STAT signaling pathway, the IFN-γ has been known as a strong inducer of M1 phenotype through STAT1 activation [50]. It is controlled by IRF5 and IRF4 which exert promotive and inhibitory effects, respectively [51]. The IL-4 and IL-10 can activate STAT3 and STAT6 to program the M2-like phenotype and also have cross talk with JNK pathway as mentioned in the JNK signaling pathway. The IL-13 can activate both M1- and M2-associated genes through STAT1, STAT3, and STAT6 activation [52]. There are two regulators of JAK/STAT pathway that affect M1/M2 reprogramming, SOCS1 and SOCS3. The SOCS1 exhibits a suppressive function on STAT1, thus leading to the M1-like phenotype inhibition, while activating STAT6 to induce M2 polarization. The SOCS3 can activate STAT1 activity to contribute M1 polarization [53, 54].

2.2.4 The Notch signaling pathway

The Notch pathway is generally known to play a fundamental role in regulating development and assist to govern the fate in response to different stimuli. There are four members of transmembrane receptors including Notch1–4. When the Notch receptors bind to their ligand family, such as Delta-like proteins (DLLs) and Jagged proteins, the Notch intracellular domain (NICD) receptors will be released into the cell nucleus and binds to RBP-J to form a transcription complex, thus driving the target gene expression [55]. For example, LPS stimulation can upregulate DLL4 which is one of the DLLs in the TLR4/NF-κB-dependent way. The increased DLL4 can lead to activated Notch signaling and induce pro-inflammatory genes, such as IL-12 and iNOS [56]. Apart from the direct function of RBP-J, it can also positively regulate IRF8 activation to promote pro-inflammatory cytokine production. And this regulation is associated with PI3K/Akt and TLR4/NF-κB pathways [57].

2.2.5 Other molecular mechanisms

Apart from the signaling pathways mentioned above, there are many other pathways involving in M1/M2 reprogramming. For example, the TLR/NF-κB pathway is important in regulating the innate immune response. TLRs can sense the microbial components and transduce signals to affect NF-κB activity. When the NF-κB is formed as p50/p65, it promotes M1-associated gene expression, while p50/p50 form has beneficial effects on M2-associated gene expression [58, 59]. It is worth noting that the hypoxia-dependent pathway also participates in M1/M2 phenotypic switch. The HIF-1α is induced under hypoxia condition and serves as a transcription factor to regulate protein production. It has been reported that HIF-1α promotes M1-like polarization by enhancing iNOS production and HIF-2α promotes M2 phenotype via increasing Arg-1 expression [60].


3. Roles of TAM polarization and Chinese medicine intervention

The roles of TAMs under physiological and pathological conditions depend on their dichotomic polarization. Generally, when infection of tissue or damage occurs, The first-responding TAMs show M1-like phenotype and secrete pro-inflammatory cytokines to defend against invading pathogens and eliminate necrotic cells. And at the latter stage, the M2-like macrophages have shown as a compensation mechanism to prohibit extensive inflammation and assist in wound healing. In cancers, the M1-like TAMs predominantly exert cytotoxicity effect on cancer cells, while the M2-like TAMs assist in modulating immunosuppressive and pro-tumoral TME for cancer progression. Nowadays, TAMs are becoming promising targets for therapeutic strategies [61, 62]. Many Chinese herbal medicines have been identified to have anti-microbial, anti-inflammatory, immune regulatory, and antitumor effects. It would be interesting to review the intervention of Chinese medicines on TAM polarization in different cancers and diseases. Here, we select some of the Chinese medicines to describe as examples.

3.1 Baicalein

Baicalein (5,6,7-trihydroxyflavone) is isolated from the Chinese herb Scutellaria baicalensis root and has many beneficial effects on antitumor, anti-inflammation, anti-fibrosis, and antimicrobial [63, 64]. The treatment of baicalein in breast cancer is the first to explain its effect on TAM regulation. In breast cancer, TAMs showed M2-like phenotype that produced TGF-β1 and enhanced tumor growth and EMT process via PI3K/Akt signaling pathway. In turn, the tumor cells secreted TGF-β1 to maintain TAMs in M2-like phenotype. The positive feedback loop between tumor cells and M2-like macrophages was formed and further contributed to tumor metastasis in the lung. Baicalein administration could block TGF-β1 via inhibiting PI3K/Akt pathway. Besides, instead of altering the population of TAMs, baicalein could drive M2-like macrophages to M1-like macrophage differentiation, with M1 markers increased. Therefore, the application of baicalein in regulating TAM polarization in breast cancer may provide a new understanding of other cancer treatments [65].

3.2 Panax notoginseng

The root of Panax notoginseng (PN) (Burk.) F.H. Chen is one of the popular Chinese herbs also known as sanqi, tianqi, or sanchi in Asia [66]. It has been widely used in many disorders for over 400 years due to its anticancer, anti-inflammatory, antiatherosclerotic, and hemostatic properties [67, 68]. Recent studies have shown that PN not only has cytotoxicity on cancer cells but also can redirect TAM polarization. It is commonly known that M2-like macrophages exert pro-tumorigenic effects on cancer, and to redirect M2 phenotype to antitumor M1 phenotype would be one of the promising strategies in cancer treatment. In many lung cancer studies, it has been reported that high doses of PN administration have direct cytotoxic effects on cancer cells, while the lower dose of PN still have inhibitory effects on tumor growth, suggesting there are other regulatory mechanisms. The in vitro study found that a lower dose of PN did not affect cancer cells, but it could reeducate M2-like macrophages toward M1 phenotypic differentiation [69]. It would help to better explain the pharmacological mechanism of PN.

3.3 Osthole

Osthole [7-methoxy-8-(3-methyl-2-butenyl)-2H-1-benzopyran-2-one] is isolated from Cnidium monnieri (Fructus Cnidii) and belongs to coumarin family, which is a benzopyrone and used as tumor-target drug carrier [70]. Osthole not only has cytotoxicity to cancer cells, such as breast cancer, lung cancer, HCC, and nasopharyngeal cancer (NPC) [71, 72, 73], but also has immunomodulatory effects on different tumors. In pancreatic tumors, osthole decreased M2-like macrophage population both in tumor site and spleen. But it did not affect M1-like macrophages. An in vitro study found that osthole could significantly inhibit STAT6 pathway and p-ERK1/2-C/EBP β signal, thus further inhibiting the M2-like macrophage polarization [74].

3.4 Emodin

Emodin (1,3,8-trihydroxy-6-methylanthraquinone) is a natural anthraquinone derivative from many Chinese herbs, and it has multiple pharmacological effects [75]. One study focused on the effects of emodin on macrophage polarization has shown that it could bidirectionally regulate both M1 and M2 phenotype programs via different signaling pathways, as well as participated in the epigenetic modification. It seems like that emodin can restrain excessive M1- or M2-like macrophages and assist in maintaining homeostasis in different pathologies. For example, in breast cancer, emodin decreased TAM infiltration and inhibited M2-polarized phenotype by suppressing STAT6 and C/EBPβ signaling pathway. Moreover, it could increase H3K27m3 to downregulate M2-related genes.

3.5 Other Chinese medicine

Many other Chinese medicines have protective functions on different diseases through regulating M1/M2 phenotypic switch (as shown in Table 1). For example, curcumin can promote macrophages toward M2-like phenotype to ameliorate liver fibrosis, and it also assists wound healing [76]. Smiglaside A and Ginsenoside Rb3 have protective functions against acute lung injury via inducing M2-like macrophage polarization [77, 78]. These findings may throw a new light for the regulatory mechanisms of Chinese medicines and promote their applications in health and diseases.

Chinese medicineM1/M2 phenotype switchDiseaseReference
Angelica sinensisM2Cardiac fibrosis[79]
BaicaleinM1Breast cancer[65]
BerberineM2Colitis; insulin resistance[80, 81]
CelastrolM2Diet-induced obesity; acute ischemic stroke[83, 84]
CorilaginM1Schistosome egg-induced hepatic fibrosis[85]
CurcuminM2Liver fibrosis; wound healing[76, 87]
Diosgenin glucosideM2Neuroinflammatory diseases[89]
EmodinM1Breast cancer[90]
Ganoderma lucidum KarstM1Inflammation[91]
GastrodinM2Cerebral palsy[92]
Ginkgolide BM2Ischemic stroke[93]
Ginsenoside Rb1M2Atherosclerosis[94]
Ginsenoside Rb3M2Acute lung injury[78]
IsoliquiritigeninM2Acute kidney injury[95]
KumatakeninM1Ovarian cancer[96]
Magnesium lithospermate BM2Neuronal injury[97]
Mylabris phalerataM1Lung carcinoma[98]
OstholeM1Pancreatic cancer[74]
PaeoniflorinM2Neuronal injury[99]
Panax notoginsengM1Lung carcinoma; influenza A virus infection[69, 100]
Pentacyclic triterpene LupeolM2Inflammatory bowel disease[101]
PterostilbeneM1Lung cancer[102]
SaponinM2Intestinal polyps[104]
Smiglaside AM2Acute lung injury[77]
Tanshinone IIAM2Acute kidney injury
Timosaponin AIIIM2Colitis[106]
Trichosanthes Kirilowii lectinM2Streptozocin-induced kidney injury[107]

Table 1.

The intervention of Chinese medicine on M1/M2 switch in different diseases.


4. Conclusions

Current studies have described the heterogeneity and adaptive plasticity of TAMs in the intrinsic and dynamic TME. They are composed of both tissue-resident macrophages and monocyte-derived macrophages and interplay with TME. The latter one is attracted and recruited to the tumor site via various signals in TME, while TAMs can produce different molecules to remodel TME. In response to different stimuli, TAMs can differentiate into either classically activated/M1 macrophages or alternatively activated/M2 macrophage which involves multiple signaling pathways. The role of TAMs depends on their dichotomic polarization in health and disease. Therefore, they are becoming potential targets for many therapeutic strategies. Chinese medicine has been widely used in a long history of Asia and shows multiple effects on different diseases. Knowing the intervention of Chinese medicine on TAMs polarization may help to better understand the principle of Chinese medicine and contribute to the comprehensive applications in many diseases.



The study was financially supported by grants from the research council of the University of Hong Kong (Project Codes: 104004092, 104004460, 104004746); the Research Grants Committee (RGC) of Hong Kong, HKSAR (Project Codes: 764708, 766211, 17152116); Wong’s Donation on Modern Oncology of Chinese Medicine (Project code: 200006276); Gala Family Trust (Project Code: 200007008); and Innovation Technology Fund of Hong Kong (ITF. Project code: 260900263).


Conflict of interest

The authors have no conflict of interest.



AP-1activator protein 1
ATMadipose tissue macrophage
CCRC-C motif chemokine receptors
CSF1colony stimulating factor
DLLDelta-like protein
EGFendothelial growth factor
FcRFc receptor
FOXO1Forkhead Box O1
GPCRG-protein-coupled receptors
HFDhigh-fat diet
HIFhypoxia inducible factor
iNOSinducible nitric oxide synthase
IRFinterferon regulatory factor
JAKJanus kinase
JNKc-Jun N-terminal kinase
MAMmetastatic-associated macrophage
MAPKmitogen-activated protein kinase
mTORmammalian target of rapamycin
NAFLDnonalcoholic fatty liver disease
NICDintracellular domain of notch receptor
NPCnasopharyngeal cancer
PDGFplatelet-derived growth factor
PIP2phosphatidylinositol 4,5-bisphosphate
PIP3phosphatidylinositol 3,4,5-trisphosphate
PNPanax notoginseng
PPARperoxisome proliferator-activated receptor
PRRpattern recognition receptor
RBP-Jrecombination signal binding protein for immunoglobulin Kappa J region
ROSreactive oxygen species
Smad3SMAD family member 3
SOCSsuppressor of cytokine signaling
STATsignal transducer and activator of transcription
TAMtumor-associated macrophages
TGFtransforming growth factor
Th1type 1 T helper
Th2type 2 T helper
TLRToll-like receptor
TMEtumor microenvironment
TRAFTNF receptor-associated factor
VEGFvascular endothelial growth factor
Ym1chitinase-like 3


  1. 1. Alamoud KA, Kukuruzinska MA. Emerging insights into Wnt/β-catenin signalling in head and neck cancer. Journal of Dental Research. 2018;97(6):665-673
  2. 2. Noy R, Pollard JWJI. Tumor-associated macrophages: From mechanisms to therapy. Immunity. 2014;41(1):49-61
  3. 3. Zhang QW et al. Prognostic significance of tumor-associated macrophages in solid tumor: A meta-analysis of the literature. Plos One. 2012;7(12):e50946
  4. 4. Guo B et al. Meta-analysis of the prognostic and clinical value of tumor-associated macrophages in adult classical Hodgkin lymphoma. BMC Medicine. 2016;14(1):159
  5. 5. Mei J et al. Prognostic impact of tumor-associated macrophage infiltration in non-small cell lung cancer: A systemic review and meta-analysis. Oncotarget. 2016;7(23):34217
  6. 6. Yin S et al. The prognostic and clinicopathological significance of tumor-associated macrophages in patients with gastric cancer: A meta-analysis. PloS One. 2017;12(1):e0170042
  7. 7. Nakatsumi H, Matsumoto M, Nakayama KI. Noncanonical pathway for regulation of CCL2 expression by an mTORC1-FOXK1 axis promotes recruitment of tumor-associated macrophages. Cell Reports. 2017;21(9):2471-2486
  8. 8. Qian BZ et al. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature. 2011;475(7355):222
  9. 9. Halama N et al. Tumoral immune cell exploitation in colorectal cancer metastases can be targeted effectively by anti-CCR5 therapy in cancer patients. Cancer Cell. 2016;29(4):587-601
  10. 10. Abraham D et al. Stromal cell-derived CSF-1 blockade prolongs xenograft survival of CSF-1-negative neuroblastoma. International Journal of Cancer. 2010;126(6):1339-1352
  11. 11. Leung SY et al. Monocyte chemoattractant protein-1 expression and macrophage infiltration in gliomas. Acta Neuropathologica. 1997;93(5):518-527
  12. 12. Negus R et al. Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of CC chemokines. The American Journal of Pathology. 1997;150(5):1723
  13. 13. Arenberg DA et al. Macrophage infiltration in human non-small-cell lung cancer: The role of CC chemokines. Cancer Immunology, Immunotherapy. 2000;49(2):63-70
  14. 14. Ueno T et al. Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clinical Cancer Research. 2000;6(8):3282-3289
  15. 15. Ohta M et al. Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human esophageal squamous cell carcinomas. International Journal of Cancer. 2002;102(3):220-224. DOI: 10.1002/ijc.10705
  16. 16. Pena CG et al. LKB1 loss promotes endometrial cancer progression via CCL2-dependent macrophage recruitment. The Journal of Clinical Investigation. 2015;125(11):4063-4076. DOI: 10.1172/JCI82152
  17. 17. Arakaki R et al. CCL2 as a potential therapeutic target for clear cell renal cell carcinoma. Cancer Medicine. 2016;5(10):2920-2933
  18. 18. Peña CG et al. LKB1 loss promotes endometrial cancer progression via CCL2-dependent macrophage recruitment. The Journal of Clinical Investigation. 2015;125(11):4063-4076
  19. 19. Liu B et al. ATF4 regulates CCL2 expression to promote endometrial cancer growth by controlling macrophage infiltration. Experimental Cell Research. 2017;360(2):105-112
  20. 20. Fujimoto H et al. Stromal MCP-1 in mammary tumors induces tumor-associated macrophage infiltration and contributes to tumor progression. International Journal of Cancer. 2009;125(6):1276-1284
  21. 21. Yoshimura T et al. Monocyte chemoattractant protein-1/CCL2 produced by stromal cells promotes lung metastasis of 4T1 murine breast cancer cells. PloS One. 2013;8(3):e58791
  22. 22. O'sullivan C, Lewis CE, Harris ALJTL. Secretion of epidermal growth factor by macrophages associated with breast carcinoma. The Lancet. 1993;342(8864):148-149
  23. 23. Shojaei F et al. Role of myeloid cells in tumor angiogenesis and growth. Trends in Cell Biology. 2008;18(8):372-378
  24. 24. Kessenbrock K, Plaks V, Werb ZJC. Matrix metalloproteinases: Regulators of the tumor microenvironment. Cell. 2010;141(1):52-67
  25. 25. Mantovani A, Sica A. Macrophages, innate immunity and cancer: Balance, tolerance, and diversity. Current Opinion in Immunology. 2010;22(2):231-237
  26. 26. Cortez-Retamozo V et al. Origins of tumor-associated macrophages and neutrophils. Proceedings of the National Academy of Sciences. 2012;109(7):2491-2496
  27. 27. Franklin RA et al. The cellular and molecular origin of tumor-associated macrophages. Science. 2014;344(6186):921-925
  28. 28. van de Laar L et al. Yolk sac macrophages, fetal liver, and adult monocytes can colonize an empty niche and develop into functional tissue-resident macrophages. Immunity. 2016;44(4):755-768
  29. 29. Mantovani A et al. Macrophage polarization: Tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends in Immunology. 2002;23(11):549-555
  30. 30. Gordon S. Alternative activation of macrophages. Nature Reviews Immunology. 2003;3(1):23
  31. 31. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nature Reviews Immunology. 2005;5(12):953
  32. 32. Mantovani A, Sica A, Locati MJI. Macrophage polarization comes of age. Immunity. 2005;23(4):344-346
  33. 33. Martinez FO, Helming L, Gordon S. Alternative activation of macrophages: An immunologic functional perspective. Annual Review of Immunology. 2009;27:451-483
  34. 34. Rhee I. Diverse macrophages polarization in tumor microenvironment. Archives of Pharmacal Research. 2016;39(11):1588-1596
  35. 35. Mantovani A, Sica A, Locati M. New vistas on macrophage differentiation and activation. European Journal of Immunology. 2007;37(1):14-16
  36. 36. Yeung OW et al. Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma. Journal of Hepatology. 2015;62(3):607-616
  37. 37. Biswas SK, Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: Cancer as a paradigm. Nature Immunology. 2010;11(10):889
  38. 38. Mantovani A et al. The chemokine system in diverse forms of macrophage activation and polarization. Trends in Immunology. 2004;25(12):677-686
  39. 39. Kumar A et al. JNK pathway signalling: A novel and smarter therapeutic targets for various biological diseases. Future Medicinal Chemistry. 2015;7(15):2065-2086
  40. 40. Zhou D et al. Macrophage polarization and function with emphasis on the evolving roles of coordinated regulation of cellular signalling pathways. Cellular Signalling. 2014;26(2):192-197
  41. 41. Weisberg SP et al. Obesity is associated with macrophage accumulation in adipose tissue. The Journal of Clinical Investigation. 2003;112(12):1796-1808
  42. 42. Luyendyk JP et al. Genetic analysis of the role of the PI3K-Akt pathway in lipopolysaccharide-induced cytokine and tissue factor gene expression in monocytes/macrophages. The Journal of Immunology. 2008;180(6):4218-4226
  43. 43. Lancaster GI, Febbraio MA. The immunomodulating role of exercise in metabolic disease[J]. Trends in Immunology, 2014;35(6):262-269
  44. 44. Covarrubias AJ, Aksoylar HI, Horng T. Control of macrophage metabolism and activation by mTOR and Akt signalling. Seminars in Immunology. Elsevier: Academic Press; 2015;27(4):286-296
  45. 45. Fukao T, Koyasu S. PI3K and negative regulation of TLR signalling. Trends in Immunology. 2003;24(7):358-363
  46. 46. Troutman TD, Bazan JF, Pasare C. Toll-like receptors, signalling adapters and regulation of the pro-inflammatory response by PI3K. Cell Cycle. 2012;11(19):3559-3567
  47. 47. Polumuri SK, Toshchakov VY, Vogel SN. Role of phosphatidylinositol-3 kinase in transcriptional regulation of TLR-induced IL-12 and IL-10 by Fcγ receptor ligation in murine macrophages. The Journal of Immunology. 2007;179(1):236-246
  48. 48. Vergadi E et al. Akt signalling pathway in macrophage activation and M1/M2 polarization. The Journal of Immunology. 2017;198(3):1006-1014
  49. 49. O’Shea JJ, Plenge RJI. JAK and STAT signalling molecules in immunoregulation and immune-mediated disease. Immunity. 2012;36(4):542-550
  50. 50. Hu X et al. Crosstalk among Jak-STAT, Toll-like receptor, and ITAM-dependent pathways in macrophage activation. Journal of Leukocyte Biology. 2007;82(2):237-243
  51. 51. Satoh T et al. Critical role of Trib1 in differentiation of tissue-resident M2-like macrophages. Nature. 2013;495(7442):524
  52. 52. Bhattacharjee A et al. IL-4 and IL-13 employ discrete signalling pathways for target gene expression in alternatively activated monocytes/macrophages. Free Radical Biology and Medicine. 2013;54:1-16
  53. 53. Qin H et al. SOCS3 deficiency promotes M1 macrophage polarization and inflammation. The Journal of Immunology. 2012;189(7):3439-3448
  54. 54. Croker BA, Kiu H, Nicholson SE. SOCS regulation of the JAK/STAT signalling pathway. In: Seminars in Cell and Developmental Biology. Elsevier: Academic Press; 2008;19(4):414-422
  55. 55. Kopan R, Ilagan MX. The canonical Notch signalling pathway: Unfolding the activation mechanism. Cell. 2009;137(2):216-233
  56. 56. Fung E et al. Delta-like 4 induces notch signalling in macrophages: Implications for inflammation. Inflammation. 2007;115(23):2948-2956
  57. 57. Liu J et al. Synergistic activation of interleukin-12 p35 gene transcription by interferon regulatory factor-1 and interferon consensus sequence-binding protein. Journal of Biological Chemistry. 2004;279(53):55609-55617
  58. 58. Porta C et al. Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor κB. Proceedings of the National Academy of Sciences. 2009;106(35):14978-14983
  59. 59. Bonizzi G, Karin M. The two NF-κB activation pathways and their role in innate and adaptive immunity. Trends in Immunology. 2004;25(6):280-288
  60. 60. Takeda N et al. Differential activation and antagonistic function of HIF-α isoforms in macrophages are essential for NO homeostasis. Genes & Development. 2010;24(5):491-501
  61. 61. Mantovani A, Allavena P, Sica A. Tumour-associated macrophages as a prototypic type II polarised phagocyte population: Role in tumour progression. European Journal of Cancer. 2004;40(11):1660-1667
  62. 62. Condeelis J, Pollard JWJC. Macrophages: Obligate partners for tumor cell migration, invasion, and metastasis. Cell. 2006;124(2):263-266
  63. 63. Bie B et al. Baicalein, a natural anti-cancer compound, alters microRNA expression profiles in Bel-7402 human hepatocellular carcinoma cells. Cellular Physiology and Biochemistry. 2017;41(4):1519-1531
  64. 64. Wang W et al. Baicalein attenuates renal fibrosis by inhibiting inflammation via down-regulating NF-κB and MAPK signal pathways. Journal of Molecular Histology. 2015;46(3):283-290
  65. 65. Zhao X et al. Baicalein suppress EMT of breast cancer by mediating tumor-associated macrophages polarization. American Journal of Cancer Research. 2018;8(8):1528
  66. 66. Liu J et al. Saponins of Panax notoginseng: Chemistry, cellular targets and therapeutic opportunities in cardiovascular diseases. Expert Opinion on investigational Drugs. 2014;23(4):523-539
  67. 67. Aplin JD. MUC-1 glycosylation in endometrium: Possible roles of the apical glycocalyx at implantation. Human Reproduction. 1999;14(suppl_2):17-25
  68. 68. Wang CZ, Anderson S, Yuan CS. Phytochemistry and anticancer potential of notoginseng. The American Journal of Chinese Medicine. 2016;44(01):23-34
  69. 69. Kim B et al. Panax notoginseng inhibits tumor growth through activating macrophage to M1 polarization. American Journal of Chinese Medicine. 2018;46(06):1369-1385. DOI: 10.1142/s0192415x18500726
  70. 70. Zhang ZR et al. Osthole: A review on its bioactivities, pharmacological properties, and potential as alternative medicine. Evidence-Based Complementary and Alternative Medicine. 2015;2015
  71. 71. Lin ZK et al. Osthole inhibits the tumorigenesis of hepatocellular carcinoma cells. Oncology Reports. 2017;37(3):1611-1618
  72. 72. Liu PY et al. Osthole induces human nasopharyngeal cancer cells apoptosis through Fas–Fas ligand and mitochondrial pathway. Environmental Toxicology. 2018;33(4):446-453
  73. 73. Xu XM et al. Osthole suppresses migration and invasion of A549 human lung cancer cells through inhibition of matrix metalloproteinase-2 and matrix metallopeptidase-9 in vitro. Molecular Medicine Reports. 2012;6(5):1018-1022
  74. 74. Wang B et al. Osthole inhibits pancreatic cancer progression by directly exerting negative effects on cancer cells and attenuating tumor-infiltrating M2 macrophages. Journal of Pharmacological Sciences. 2018;137(3):290-298. DOI: 10.1016/j.jphs.2018.07.007
  75. 75. Wang JB et al. Hepatotoxicity or hepatoprotection? Pattern recognition for the paradoxical effect of the Chinese herb Rheum palmatum L. in treating rat liver injury. PloS One. 2011;6(9):e24498
  76. 76. Zhao XA et al. Curcumin reduces Ly6C(hi) monocyte infiltration to protect against liver fibrosis by inhibiting Kupffer cells activation to reduce chemokines secretion. Biomedicine and Pharmacotherapy. 2018;106:868-878. DOI: 10.1016/j.biopha.2018.07.028
  77. 77. Wang Y et al. Smiglaside A ameliorates LPS-induced acute lung injury by modulating macrophage polarization via AMPK-PPARgamma pathway. Biochemical Pharmacology. 2018;156:385-395. DOI: 10.1016/j.bcp.2018.09.002
  78. 78. Yang J et al. Ginsenoside Rg3 attenuates lipopolysaccharide-induced acute lung injury via MerTK-dependent activation of the PI3K/AKT/mTOR pathway. Frontiers in Pharmacology. 2018;9:850. DOI: 10.3389/fphar.2018.00850
  79. 79. Lee TM et al. Preconditioned adipose-derived stem cells ameliorate cardiac fibrosis by regulating macrophage polarization in infarcted rat hearts through the PI3K/STAT3 pathway. Laboratory Investigation. 2019:1
  80. 80. Liu Y et al. Berberine inhibits macrophage M1 polarization via AKT1/SOCS1/NF-kappaB signalling pathway to protect against DSS-induced colitis. International Immunopharmacology. 2018;57:121-131. DOI: 10.1016/j.intimp.2018.01.049
  81. 81. Ye L et al. Inhibition of M1 macrophage activation in adipose tissue by berberine improves insulin resistance. Life Sciences. 2016;166:82-91. DOI: 10.1016/j.lfs.2016.09.025
  82. 82. Wang K et al. Bergenin, acting as an agonist of PPARgamma, ameliorates experimental colitis in mice through improving expression of SIRT1, and therefore inhibiting NF-kappaB-mediated macrophage activation. Frontiers in Pharmacology. 2017;8:981. DOI: 10.3389/fphar.2017.00981
  83. 83. Luo D et al. Natural product celastrol suppressed macrophage M1 polarization against inflammation in diet-induced obese mice via regulating Nrf2/HO-1, MAP kinase and NF-kappaB pathways. Aging (Albany NY). 2017;9(10):2069
  84. 84. Jiang M et al. Celastrol treatment protects against acute ischemic stroke-induced brain injury by promoting an IL-33/ST2 axis-mediated microglia/macrophage M2 polarization. Journal of Neuroinflammation. 2018;15(1):78. DOI: 10.1186/s12974-018-1124-6
  85. 85. Li YQ et al. Corilagin counteracts IL-13Ralpha1 signalling pathway in macrophages to mitigate schistosome egg-induced hepatic fibrosis. Frontiers in Cellular and Infection Microbiology. 2017;7:443. DOI: 10.3389/fcimb.2017.00443
  86. 86. Li J et al. Crocin alleviates coronary atherosclerosis via inhibiting lipid synthesis and inducing M2 macrophage polarization. International Immunopharmacology. 2018;55:120-127. DOI: 10.1016/j.intimp.2017.11.037
  87. 87. Yang Z et al. Curcumin-mediated bone marrow mesenchymal stem cell sheets create a favorable immune microenvironment for adult full-thickness cutaneous wound healing. Stem Cell Research and Therapy. 2018;9(1):21. DOI: 10.1186/s13287-018-0768-6
  88. 88. Kou Y et al. Connexin 43 upregulation by dioscin inhibits melanoma progression via suppressing malignancy and inducing M1 polarization. International Journal of Cancer. 2017;141(8):1690-1703. DOI: 10.1002/ijc.30872
  89. 89. Wang S et al. Diosgenin glucoside provides neuroprotection by regulating microglial M1 polarization. International Immunopharmacology. 2017;50:22-29. DOI: 10.1016/j.intimp.2017.06.008
  90. 90. Iwanowycz S et al. Emodin inhibits breast cancer growth by blocking the tumor-promoting feedforward loop between cancer cells and macrophages. Molecular Cancer Therapeutics. 2016;15(8):1931-1942. DOI: 10.1158/1535-7163.Mct-15-0987
  91. 91. Sun LX et al. The improvement of M1 polarization in macrophages by glycopeptide derived from Ganoderma lucidum. Immunologic Research. 2017;65(3):658-665. DOI: 10.1007/s12026-017-8893-3
  92. 92. Jia J et al. BCL6 mediates the effects of gastrodin on promoting M2-like macrophage polarization and protecting against oxidative stress-induced apoptosis and cell death in macrophages. Biochemical and Biophysical Research Communications. 2017;486(2):458-464. DOI: 10.1016/j.bbrc.2017.03.062
  93. 93. Shu ZM et al. Ginkgolide B protects against ischemic stroke via modulating microglia polarization in mice. CNS Neuroscience and Therapeutics. 2016;22(9):729-739. DOI: 10.1111/cns.12577
  94. 94. Zhang X et al. Ginsenoside Rb1 enhances atherosclerotic plaque stability by skewing macrophages to the M2 phenotype. Journal of Cellular and Molecular Medicine. 2018;22(1):409-416. DOI: 10.1111/jcmm.13329
  95. 95. Tang Y et al. Isoliquiritigenin attenuates LPS-induced AKI by suppression of inflammation involving NF-κB pathway. American Journal of Translational Research. 2018;10(12):4141
  96. 96. Woo JH et al. Effect of kumatakenin isolated from cloves on the apoptosis of cancer cells and the alternative activation of tumor-associated macrophages. Journal of Agricultural and Food Chemistry. 2017;65(36):7893-7899. DOI: 10.1021/acs.jafc.7b01543
  97. 97. Tai Y, Qiu Y, Bao Z. Magnesium lithospermate B suppresses lipopolysaccharide-induced neuroinflammation in BV2 microglial cells and attenuates neurodegeneration in lipopolysaccharide-injected mice. Journal of Molecular Neuroscience. 2018;64(1):80-92. DOI: 10.1007/s12031-017-1007-9
  98. 98. Chung HS, Lee BS, Ma JY. Ethanol extract of Mylabris phalerata inhibits M2 polarization induced by recombinant IL-4 and IL-13 in murine macrophages. Evidence-based Complementary and Alternative Medicine. 2017;2017:4218468. DOI: 10.1155/2017/4218468
  99. 99. Luo XQ et al. Paeoniflorin exerts neuroprotective effects by modulating the M1/M2 subset polarization of microglia/macrophages in the hippocampal CA1 region of vascular dementia rats via cannabinoid receptor 2. Chinese Medicine. 2018;13:14. DOI: 10.1186/s13020-018-0173-1
  100. 100. Choi JG et al. Protective effect of panax notoginseng root water extract against influenza A virus infection by enhancing antiviral interferon-mediated immune responses and natural killer cell activity. Frontiers in Immunology. 2017;8:1542. DOI: 10.3389/fimmu.2017.01542
  101. 101. Zhu Y et al. The pentacyclic triterpene Lupeol switches M1 macrophages to M2 and ameliorates experimental inflammatory bowel disease. International Immunopharmacology. 2016;30:74-84. DOI: 10.1016/j.intimp.2015.11.031
  102. 102. Huang WC et al. Modulation of macrophage polarization and lung cancer cell stemness by MUC1 and development of a related small-molecule inhibitor pterostilbene. Oncotarget. 2016;7(26):39363-39375. DOI: 10.18632/oncotarget.8101
  103. 103. Xu X et al. Punicalagin, a PTP1B inhibitor, induces M2c phenotype polarization via up-regulation of HO-1 in murine macrophages. Free Radical Biology and Medicine. 2017;110:408-420. DOI: 10.1016/j.freeradbiomed.2017.06.014
  104. 104. Chen L et al. Triterpenoid herbal saponins enhance beneficial bacteria, decrease sulfate-reducing bacteria, modulate inflammatory intestinal microenvironment and exert cancer preventive effects in ApcMin/+ mice. Oncotarget. 2016;7(21):31226-31242. DOI: 10.18632/oncotarget.8886
  105. 105. Gao S et al. Tanshinone IIA alleviates inflammatory response and directs macrophage polarization in lipopolysaccharide-stimulated RAW264. Cell. 2018;7:1-12
  106. 106. Lim SM et al. Timosaponin AIII and its metabolite sarsasapogenin ameliorate colitis in mice by inhibiting NF-kappaB and MAPK activation and restoring Th17/Treg cell balance. International Immunopharmacology. 2015;25(2):493-503. DOI: 10.1016/j.intimp.2015.02.016
  107. 107. Jiandong L et al. Trichosanthes kirilowii lectin ameliorates streptozocin-induced kidney injury via modulation of the balance between M1/M2 phenotype macrophage. Biomedicine and Pharmacotherapy. 2018;109:93-102. DOI: 10.1016/j.biopha.2018.10.060

Written By

Yuanjun Lu, Hor Yue Tan, Ning Wang and Yibin Feng

Submitted: 21 February 2019 Reviewed: 24 April 2019 Published: 29 May 2019